Nuclear Medicine and Nanomaterials Laboratory

Using radionuclides to target cancer cells has been in clinical trials for over twenty years — but it continues to challenge how clinical trials are run across borders. Nanometer-sized particles are present in many different materials, and combining that knowledge to develop our new materials is the way to create a novel platform for cancer treatment.